Cassia Capital Partners’s Bristol-Myers Squibb BMY Stock Holding History

Cassia Capital Partners’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-8,222	Closed	-$425K	–	63
2024 Q3	$425K	Buy	8,222 +235	+3%	+$11K	0.28%	51
2024 Q2	$332K	Sell	7,987 -3,792	-32%	-$170K	0.22%	53
2024 Q1	$639K	Buy	11,779 +3,681	+45%	+$188K	0.42%	45
2023 Q4	$416K	Buy	8,098 +167	+2%	+$8.77K	0.34%	50
2023 Q3	$460K	Buy	7,931 +182	+2%	+$11.2K	0.38%	37
2023 Q2	$496K	Buy	7,749 +1,660	+27%	+$111K	0.39%	27
2023 Q1	$422K	Sell	6,089 -107	-2%	-$7.55K	0.34%	24
2022 Q4	$446K	Buy	+6,196	New	+$467K	0.37%	25
2021 Q4	–	Sell	-17,724	Closed	-$1.05M	–	78
2021 Q3	$1.05M	Buy	+17,724	New	+$1.17M	0.72%	73

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Cassia Capital Partners's BMY Position: Q4 2024 in Review

Cassia Capital Partners sold out of Bristol-Myers Squibb (BMY) in Q4 2024, closing a stake of 8,222 shares — an estimated $425K sold.

Cassia Capital Partners first reported a position in BMY in Q3 2021 and held it in 9 quarters. The position peaked at $1.05M in Q3 2021. 2,486 funds tracked by Wall St. Rank hold BMY as of Q4 2024.

Cassia Capital Partners reported no remaining Bristol-Myers Squibb position as of Q4 2024 after selling out during the quarter.
Cassia Capital Partners sold 8,222 Bristol-Myers Squibb shares in Q4 2024, an estimated $425K.
Cassia Capital Partners first reported a position in Bristol-Myers Squibb in Q3 2021 and held it in 9 quarters.
Cassia Capital Partners's Bristol-Myers Squibb position peaked at $1.05M in Q3 2021.
2,486 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2024.

Based on Cassia Capital Partners's 13F filing for Q4 2024, filed 27 Jan 2025.